Schürch F, Meier P J, Wyss P A
Schweizerisches Toxikologisches informationszentrum (STIZ), Universitätsspital Zürich.
Dtsch Med Wochenschr. 1996 Aug 16;121(33):1003-8. doi: 10.1055/s-2008-1043098.
As previous single case reports have indicated that acute poisoning with thioridazine can be potentially dangerous, an investigation was undertaken to find out whether the risk of severe poisoning in adults and children can be judged from the amount of the drug that has been taken.
In a case-control study 202 medical notes of 202 patients were analysed (141 adults, aged 16-82 years; 61 children, aged 0.3-15 years) in which thioridazine was the only potentially harmful substance taken, the precise amount swallowed was known and the drug was the certain or probable cause of the signs. 30 children were excluded from the study, because their body weight was not known.
Mild thioridazine poisoning was characterized by somnolence, tremor, ataxia and dysarthria. The severity of the poisoning and the degree of disorder of consciousness correlated significantly with the amount of thioridazine taken. Severe intoxication with coma and ventricular arrhythmias was observed at a dose of 2 g and more. While the disorder of consciousness completely regressed in the first 24 hours, in a few of the patients the cardiac arrhythmias persisted for up to 28 hours after the drug intake. Charcoal administration seemed to influence the course favourably.
Prolonged, intensive care supervision and treatment are essential if more than 2 g thioridazine have been swallowed. In addition to standard treatment with gastric lavage charcoal should be given as early as possible to limit absorption.
正如之前的单例报告所指出的,硫利达嗪急性中毒可能具有潜在危险性,因此开展了一项调查,以确定是否可以根据成人和儿童摄入的药物量来判断严重中毒的风险。
在一项病例对照研究中,分析了202例患者的202份病历(141名成人,年龄在16至82岁之间;61名儿童,年龄在0.3至15岁之间),这些患者摄入的唯一潜在有害物质为硫利达嗪,已知准确的吞咽量,且该药物是症状的确定或可能病因。30名儿童被排除在研究之外,因为他们的体重未知。
轻度硫利达嗪中毒的特征为嗜睡、震颤、共济失调和构音障碍。中毒的严重程度和意识障碍程度与硫利达嗪的摄入量显著相关。摄入2克及以上剂量时观察到严重中毒伴昏迷和室性心律失常。虽然意识障碍在最初24小时内完全消退,但少数患者在服药后心律失常持续长达28小时。给予活性炭似乎对病程有有利影响。
如果吞服了超过2克的硫利达嗪,必须进行长期、强化的重症监护和治疗。除了用洗胃进行标准治疗外,应尽早给予活性炭以限制吸收。